Search by session name | American Diabetes Association
82nd Scientific Sessions Corporate Symposia
ADA Standards of Care 2022 Spotlight—Prevention or Delay of Type 2 Diabetes and Associated Comorbidities
Advancing Therapeutics for Diabetic Kidney Disease—Top Research Abstracts (With ADA Presidents' Select Abstract Presentation)
Apoptosis—No Time to Die (With ADA Presidents' Select Abstract Presentation)
Clinical Nutrition
Clinical Pearls in the Practical use of Automated Insulin Delivery Systems
COVID-19 and Diabetes
Diabetes Care and Education Specialists DCESs Value—Positive Impact of DCESs on Therapeutic Inertia
Emerging Data on the Immune-Islet Interface in Diabetes
Evolving Methods for Characterizing Glycemic Control through Continuous Glucose Monitoring
From Paper to Practice—The Bridge between Research and Clinical Practice in Preventing Diabetes Foot Complications
From the Origins of the Adipocyte to Immunomodulatory and Metabolic Signaling
Hypoglycemia, CGM Metrics, and HbA1c—Patient and Clinician Perspectives
Improving Outcomes—A Multidisciplinary Year in Review
Innate Immunity in Diabetes
Insulin Access—Challenges and Recommendations
Machine Learning in Diabetes
Micropeptides and Signaling
Mitigating ASCVD Risk in Diabetes— Update
New Strategies for Insulin use in Type 2 Diabetes
Noninvasive Imaging of the Liver—What Should You Understand, and How Can You Help Your Patients
Not So Sweet? Low-Calorie Sweeteners, Obesity and Metabolic Health
Novel Methodologies for Assessing Islet Function
Pediatric Type 1 Diabetes (With ADA President's Select Abstract Presentation)
Race, Racism, and Diabetes Research
Real-Time, Real-Life Measurement of the Patient Experience with Blood Glucose Management—Ecological Momentary Assessment and Continuous Glucose Monitoring
Revisiting Hyperinsulinemia as the Primary Defect in Type 2 Diabetes Pathogenesis
Statins in Diabetes
The Role of Kidney in ASCVD
Top 5 Nutrition Controversies